These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 21466618)
1. Relationships among insulin resistance, type 2 diabetes, essential hypertension, and cardiovascular disease: similarities and differences. Reaven GM J Clin Hypertens (Greenwich); 2011 Apr; 13(4):238-43. PubMed ID: 21466618 [TBL] [Abstract][Full Text] [Related]
2. Insulin resistance and hypertension. Patients in double jeopardy for cardiovascular disease. McLaughlin T; Reaven G Geriatrics; 2000 Jun; 55(6):28-32, 35. PubMed ID: 10872343 [TBL] [Abstract][Full Text] [Related]
3. Insulin resistance: the link between obesity and cardiovascular disease. Reaven GM Med Clin North Am; 2011 Sep; 95(5):875-92. PubMed ID: 21855697 [TBL] [Abstract][Full Text] [Related]
4. [Insulin resistance and cardiovascular complications]. Janka HU Wien Klin Wochenschr; 1994; 106(24):758-62. PubMed ID: 7846894 [TBL] [Abstract][Full Text] [Related]
5. Banting lecture 1988. Role of insulin resistance in human disease. Reaven GM Diabetes; 1988 Dec; 37(12):1595-607. PubMed ID: 3056758 [TBL] [Abstract][Full Text] [Related]
10. The role of insulin resistance and hyperinsulinemia in coronary heart disease. Reaven GM Metabolism; 1992 May; 41(5 Suppl 1):16-9. PubMed ID: 1574008 [TBL] [Abstract][Full Text] [Related]
11. Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease. Jia G; Sowers JR Hypertension; 2021 Nov; 78(5):1197-1205. PubMed ID: 34601960 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance. Masuo K; Rakugi H; Ogihara T; Esler MD; Lambert GW Curr Diabetes Rev; 2010 Mar; 6(2):58-67. PubMed ID: 20034369 [TBL] [Abstract][Full Text] [Related]
13. Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance. Watson KE; Peters Harmel AL; Matson G J Cardiovasc Pharmacol Ther; 2003 Dec; 8(4):253-60. PubMed ID: 14740074 [TBL] [Abstract][Full Text] [Related]
14. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. DeFronzo RA; Ferrannini E Diabetes Care; 1991 Mar; 14(3):173-94. PubMed ID: 2044434 [TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of insulin resistance in human disease. Reaven GM Physiol Rev; 1995 Jul; 75(3):473-86. PubMed ID: 7624391 [TBL] [Abstract][Full Text] [Related]
16. Cardiometabolic risk management in type 2 diabetes and obesity. Taylor AM Curr Diab Rep; 2008 Oct; 8(5):345-52. PubMed ID: 18778582 [TBL] [Abstract][Full Text] [Related]
17. [Hypertension and insulin resistance]. Voiculescu A; Kutkuhn B; Rösen P; Grabensee B Wien Klin Wochenschr; 1997 Oct; 109(19):758-66. PubMed ID: 9441522 [TBL] [Abstract][Full Text] [Related]
18. [Hypertension, microalbuminuria and insulin resistance in diabetes mellitus]. Bretzel RG Wien Klin Wochenschr; 1994; 106(24):774-92. PubMed ID: 7846897 [TBL] [Abstract][Full Text] [Related]
19. Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders. Resnick LM Am J Med; 1992 Aug; 93(2A):11S-20S. PubMed ID: 1387762 [TBL] [Abstract][Full Text] [Related]
20. Insulin resistance, hyperinsulinemia, and hypertension: causes, consequences, or merely correlations? Hall JE; Brands MW; Zappe DH; Alonso Galicia M Proc Soc Exp Biol Med; 1995 Apr; 208(4):317-29. PubMed ID: 7700881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]